Syed Rizvi
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
-
- Multiple Sclerosis Research Studies
Papers in
-
- Histone Deacetylase Inhibitors Research 23
- Protein Degradation and Inhibitors 15
-
- Multiple Sclerosis Research Studies 17
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Lauren Krupp (3 shared papers)David S. Siegel (10 shared papers)Mark Agius (2 shared papers)J. Garcia‐Vargas (10 shared papers)Justin L. Ricker (8 shared papers)Victoria M. Richon (4 shared papers)César Sanz-Rodrı́guez (2 shared papers)Keisho Chìn (2 shared papers)
- Journals
- Blood (19 papers)Journal of Clinical Oncology (10 papers)Neurology (8 papers)Multiple Sclerosis and Related Disorders (3 papers)Pacing and Clinical Electrophysiology (2 papers)
- Partner nations
- United StatesBelgiumJapan
In The Last Decade
Syed Rizvi
74 papers receiving 1.9k citations
Syed Rizvi's Hit Papers
Peers
Comparison fields: 5 of 114
- Hematology 361
- Pathology and Forensic Medicine 554
- Oncology 559
- Gastroenterology 84
- Dermatology 117
Countries citing papers authored by Syed Rizvi
This map shows the geographic impact of Syed Rizvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Syed Rizvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Syed Rizvi more than expected).
Fields of papers citing papers by Syed Rizvi
This network shows the impact of papers produced by Syed Rizvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Syed Rizvi. The network helps show where Syed Rizvi may publish in the future.
Co-authors
The 25 scholars most cited alongside Syed Rizvi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study Hit paper breakdown → | 2013 | 390 |
| 2 | 2008 | 170 | |
| 3 | 2009 | 161 | |
| 4 | 2011 | 142 | |
| 5 | 2011 | 88 | |
| 6 | 2019 | 85 | |
| 7 | 2009 | 76 | |
| 8 | 2020 | 65 | |
| 9 | 2012 | 57 | |
| 10 | 2004 | 57 | |
| 11 | 2002 | 49 | |
| 12 | 2004 | 48 | |
| 13 | 2006 | 38 | |
| 14 | 2012 | 38 | |
| 15 | 2016 | 38 | |
| 16 | 2008 | 37 | |
| 17 | 2007 | 28 | |
| 18 | 2015 | 28 | |
| 19 | 2004 | 27 | |
| 20 | 2019 | 25 |
About Syed Rizvi
Syed Rizvi is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Hematology, Oncology and Neurology, having authored 78 papers that have together received 2.0k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (23 papers), Multiple Sclerosis Research Studies (17 papers), Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (15 papers), Lymphoma Diagnosis and Treatment (7 papers), Peripheral Neuropathies and Disorders (6 papers), Cutaneous lymphoproliferative disorders research (6 papers) and Polyomavirus and related diseases (4 papers). The work is most often cited by research in Hematology (361 citations), Pathology and Forensic Medicine (554 citations), Oncology (559 citations), Gastroenterology (84 citations) and Dermatology (117 citations). Syed Rizvi has collaborated with scholars based in United States, Belgium and Japan. Frequent co-authors include Lauren Krupp, David S. Siegel, Mark Agius, J. Garcia‐Vargas, Justin L. Ricker, Victoria M. Richon, César Sanz-Rodrı́guez, Keisho Chìn, Yeul Hong Kim and Atsushi Ohtsu. Their work appears in journals such as Blood, Journal of Clinical Oncology, Neurology, Multiple Sclerosis and Related Disorders and Pacing and Clinical Electrophysiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.